<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34009992</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-3907</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>Journal of proteome research</Title><ISOAbbreviation>J Proteome Res</ISOAbbreviation></Journal><ArticleTitle>Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome.</ArticleTitle><Pagination><StartPage>3315</StartPage><EndPage>3329</EndPage><MedlinePgn>3315-3329</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jproteome.1c00224</ELocationID><Abstract><AbstractText>We present a multivariate metabotyping approach to assess the functional recovery of nonhospitalized COVID-19 patients and the possible biochemical sequelae of "Post-Acute COVID-19 Syndrome", colloquially known as long-COVID. Blood samples were taken from patients ca. 3 months after acute COVID-19 infection with further assessment of symptoms at 6 months. Some 57% of the patients had one or more persistent symptoms including respiratory-related symptoms like cough, dyspnea, and rhinorrhea or other nonrespiratory symptoms including chronic fatigue, anosmia, myalgia, or joint pain. Plasma samples were quantitatively analyzed for lipoproteins, glycoproteins, amino acids, biogenic amines, and tryptophan pathway intermediates using Nuclear Magnetic Resonance (NMR) spectroscopy and mass spectrometry. Metabolic data for the follow-up patients (<i>n</i> = 27) were compared with controls (<i>n</i> = 41) and hospitalized severe acute respiratory syndrome SARS-CoV-2 positive patients (<i>n</i> = 18, with multiple time-points). Univariate and multivariate statistics revealed variable patterns of functional recovery with many patients exhibiting residual COVID-19 biomarker signatures. Several parameters were persistently perturbed, e.g., elevated taurine (<i>p</i> = 3.6 &#xd7; 10<sup>-3</sup> versus controls) and reduced glutamine/glutamate ratio (<i>p</i> = 6.95 &#xd7; 10<sup>-8</sup> versus controls), indicative of possible liver and muscle damage and a high energy demand linked to more generalized tissue repair or immune function. Some parameters showed near-complete normalization, e.g., the plasma apolipoprotein B100/A1 ratio was similar to that of healthy controls but significantly lower (<i>p</i> = 4.2 &#xd7; 10<sup>-3</sup>) than post-acute COVID-19 patients, reflecting partial reversion of the metabolic phenotype (phenoreversion) toward the healthy metabolic state. Plasma neopterin was normalized in all follow-up patients, indicative of a reduction in the adaptive immune activity that has been previously detected in active SARS-CoV-2 infection. Other systemic inflammatory biomarkers such as GlycA and the kynurenine/tryptophan ratio remained elevated in some, but not all, patients. Correlation analysis, principal component analysis (PCA), and orthogonal-partial least-squares discriminant analysis (O-PLS-DA) showed that the follow-up patients were, as a group, metabolically distinct from controls and partially comapped with the acute-phase patients. Significant systematic metabolic differences between asymptomatic and symptomatic follow-up patients were also observed for multiple metabolites. The overall metabolic variance of the symptomatic patients was significantly greater than that of nonsymptomatic patients for multiple parameters (&#x3c7;<sup>2</sup><i>p</i> = 0.014). Thus, asymptomatic follow-up patients including those with post-acute COVID-19 Syndrome displayed a spectrum of multiple persistent biochemical pathophysiology, suggesting that the metabolic phenotyping approach may be deployed for multisystem functional assessment of individual post-acute COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holmes</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0556-8389</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wist</LastName><ForeName>Julien</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3416-2572</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chemistry Department, Universidad del Valle, 76001 Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuda</LastName><ForeName>Reika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodge</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9193-0462</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitschke</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimhofer</LastName><ForeName>Torben</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7158-9930</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loo</LastName><ForeName>Ruey Leng</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0001-5307-5709</Identifier><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Begum</LastName><ForeName>Sofina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boughton</LastName><ForeName>Berin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6342-9814</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Rongchang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morillon</LastName><ForeName>Aude-Claire</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Sung-Tong</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Drew</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Monique</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bong</LastName><ForeName>Sze-How</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-3313-5097</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gay</LastName><ForeName>Melvin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bruker Pty. Ltd., Preston, VIC 3072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edgar</LastName><ForeName>Dale W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>State Adult Burn Unit, Fiona Stanley Hospital, Murdoch, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Burn Injury Research Node, The University of Notre Dame, Fremantle, WA 6160, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindon</LastName><ForeName>John C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-0916-6360</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Fiona Stanley Hospital, Medical School, University of Western Australia,Harry Perkins Building, Murdoch, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeap</LastName><ForeName>Bu B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Medical School, University of Western Australia, Harry Perkins Building, Murdoch, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettersson</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Singapore National NeuroScience Centre, Mandalay Road, Singapore 308232, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lee Kong Chian School of Medicine. Nanyang Technological University, Mandalay Road, Singapore 308232, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Science Centre, Sunway University, Kuala Lumpur 47500, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spraul</LastName><ForeName>Manfred</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bruker Biospin GmbH, Ettlingen 76275, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>Hartmut</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bruker Biospin GmbH, Ettlingen 76275, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawler</LastName><ForeName>Nathan G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0001-9649-425X</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0094-5245</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whiley</LastName><ForeName>Luke</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9088-4799</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Jeremy K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-8123-8349</Identifier><AffiliationInfo><Affiliation>Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, 5 Robin Warren Drive, Perth, WA 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Imperial College London, Level 1, Faculty Building, South Kensington Campus, London SW7 2AZ, U.K.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Proteome Res</MedlineTA><NlmUniqueID>101128775</NlmUniqueID><ISSNLinking>1535-3893</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008074">Lipoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008074" MajorTopicYN="N">Lipoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">amino acids</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">lipoproteins</Keyword><Keyword MajorTopicYN="N">long-COVID syndrome</Keyword><Keyword MajorTopicYN="N">multiorgan disease</Keyword><Keyword MajorTopicYN="N">phenoconversion</Keyword><Keyword MajorTopicYN="N">phenoreversion</Keyword><Keyword MajorTopicYN="N">plasma</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>17</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34009992</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>